Mirus LLC
Records under this name other than the patents Mirus LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 104 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,137,695 | Polyconjugates for in Vivo Delivery of Polynucleotides now held by Arrowhead Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 7,985,406 | Membrane Active Heteropolymers now held by Arrowhead Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 9,107,899 | Metal Alloys for Medical Devices Term ended Ended no later than Aug 4, 2026 · Low confidence | Term ended | Ended no later than Aug 4, 2026 | Low confidence |
| US 7,628,802 | Stent with Micro-Latching Hinge Joints Term ended Term ended Jul 13, 2026 · High confidence | Term ended | Term ended Jul 13, 2026 | High confidence |
| US 7,540,995 | Process for Forming an Improved Metal Alloy Stent Term ended Ended no later than Jul 10, 2026 · Medium confidence | Term ended | Ended no later than Jul 10, 2026 | Medium confidence |
| US 9,993,625 | Biodegradable Protrusions on Inflatable Device Lapsed on the fee record Ended Jun 12, 2026 · High confidence | Lapsed on the fee record | Ended Jun 12, 2026 | High confidence |
| US 7,803,181 | Ostial Stent Term ended Ended no later than Mar 8, 2026 · Medium confidence | Term ended | Ended no later than Mar 8, 2026 | Medium confidence |
| US 8,740,973 | Polymer Biodegradable Medical Device Term ended Term ended Feb 18, 2026 · Medium confidence | Term ended | Term ended Feb 18, 2026 | Medium confidence |
| US 7,682,626 | Polyvinylethers for Delivery of Polynucleotides to Mammalian Cells now held by Arrowhead Pharmaceuticals, Inc. Term ended Term ended Feb 12, 2026 · High confidence | Term ended | Term ended Feb 12, 2026 | High confidence |
| US 7,648,590 | Metal Alloy for a Stent Term ended Ended no later than Nov 18, 2025 · Medium confidence | Term ended | Ended no later than Nov 18, 2025 | Medium confidence |